AMGEN PRESENTS NEW LUMAKRAS CODEBREAK 200 CNS DATA AT ASCO 2023

THOUSAND OAKS - Amgen today announced the presentation of new data from the CodeBreaK clinical trial program, the most comprehensive global development program in patients with KRAS G12C-mutated... | June 5, 2023

Related Keywords

Houston ,Texas ,United States ,Taiwan ,Puerto Rico ,Mexico ,Brazil ,Saudi Arabia ,Macao ,Macau General ,Macau ,South Korea ,Canada ,Russia ,Singapore ,Japan ,Australia ,Malaysia ,United Arab Emirates ,Chicago ,Illinois ,Tennessee ,Thailand ,United Kingdom ,Turkey ,Argentina ,Kuwait ,Qatar ,Colombia ,Hong Kong ,Israel ,Switzerland ,American ,America ,Great Britain ,Davidm Reese ,Jessica Akopyan ,Davids Hong ,Melissal Johnson ,European Union ,Kyowa Kirin Co Ltd ,Drug Administration ,Teneobio Inc ,Sarah Cannon Research Institute At Tennessee Oncology ,American Society Of Clinical Oncology ,Therapeutics Inc ,Beigene Ltd ,Exchange Commission ,Chemocentryx Inc ,Lung Cancer Research ,Japan Oncology Group ,University Of Texas Md Anderson Cancer Center ,Amgen ,Clinical Oncology ,Annual Meeting ,Cancer Research ,Cannon Research Institute ,Lung Cancer Non Small Cell Metastatic ,Consistent Clinical Benefit Across ,Investigational Cancer Therapeutics ,Cancer Center ,Gastrointestinal Cancer Colorectal ,Arab Emirates ,Non Small Cell Lung Cancer ,Advanced Colorectal Cancer ,Lung Disease ,Dow Jones Industrial Average ,Best Employer ,Sustainable Companie ,Prime Therapeutics ,News Publishing ,Amgen Inc Stock Exchange ,News ,Information ,Press Release ,Thousand ,Oaks ,Oday ,Nnounced ,The ,Presentation ,F ,Few ,Data ,Rom ,Odebreak ,Linical ,Trial ,Most ,Comprehensive ,Lobal ,Development ,Program ,N ,Patients ,Ith ,Ras Amgn Us0311621009 ,